{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"VREOF","limit":50},"count":50,"signals":[{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":68,"context":"censed cannabis stores within each U.S. state in which we operate. Vireo is not dependent upon a single customer, or a few customers, and the loss of any one or more of our customers would not have a material adverse effect on the business. No customer accounted for 10% or more of our consolidated net revenue during the fiscal years ended December 31, 2025 or 2024.  Retail Strategy We have invested substantial resources","filed_date":"2026-03-17","accession":"0001104659-26-029561","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029561.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":100,"match_count":14,"context":"he notes to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K. **Pending Transactions** In addition to the completed mergers described above, the Company has entered into definitive agreements and arrangements relating to several pending transactions that had not closed as of December 31, 2025. *Schwazze Transaction* On October 10, 2025, Vireo Health of Colorado, LLC, a wholly owned subsi","filed_date":"2026-03-17","accession":"0001104659-26-029561","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029561.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":100,"match_count":15,"context":"y has served as a director of Vireo (and its predecessors Goodness Growth Holdings Inc./Vireo Health International, Inc./Vireo Health, Inc./Minnesota Medical Solutions LLC) since July2014, and he was appointed Executive Chairman of Vireo in February2023. Dr.Kingsley has served as Co-Executive Chairman of the Board since December2024. Dr.Kingsley has expansive experience in starting medical cannabis companies in well-regulate","filed_date":"2025-05-09","accession":"0001140361-25-018064","full_text":"https://origin.rootz.global/static/filing/0001140361-25-018064.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":37,"context":".17 |  Solvency |  48 | | |  SECTION 7.18 |  Locations of Offices, Records and Collateral |  48 | | |  SECTION 7.19 |  Compliance with Laws and Permits; Authorizations |  48 | | |  SECTION 7.20 |  No Material Adverse Effect |  49 | | |  SECTION 7.21 |  Contractual or Other Restrictions |  49 | | |  SECTION 7.22 |  Collective Bargaining Agreements; Officers |  49 | | |  SECTION 7.24 |  Insurance |  49 | | |  SECTION 7.25","filed_date":"2025-01-03","accession":"0001104659-25-000793","full_text":"https://origin.rootz.global/static/filing/0001104659-25-000793.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":100,"match_count":15,"context":"a0;2014 to February&#xa0;2023. Dr.&#xa0;Kingsley has served as a director of Goodness Growth (and its predecessors Vireo Health, Inc./Minnesota Medical Solutions LLC) since July&#xa0;2014, and he was appointed Executive Chairman of Goodness Growth in February&#xa0;2023. Dr.&#xa0; Kingsley has expansive experience in starting medical cannabis companies in well-regulated, limited-license states with narrow timelines for implem","filed_date":"2024-05-10","accession":"0001140361-24-025320","full_text":"https://origin.rootz.global/static/filing/0001140361-24-025320.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":27,"context":"d epidemics may adversely impact our business. Emerging infectious diseases or the threat of outbreaks of viruses or other contagions or epidemic diseases (such as the COVID-19 pandemic) could have a material adverse effect on the Company by causing operational and supply chain delays and disruptions (including as a result of government regulation and prevention measures), labor shortages and shutdowns, social unrest, b","filed_date":"2024-04-01","accession":"0001558370-24-004519","full_text":"https://origin.rootz.global/static/filing/0001558370-24-004519.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":15,"context":"COVID-19) may adversely impact our business. Emerging infectious diseases or the threat of outbreaks of viruses or other contagions or epidemic diseases, including the COVID-19 outbreak, could have a material adverse effect on the Company by causing operational and supply chain delays and disruptions (including as a result of government regulation and prevention measures), labor shortages and shutdowns, social unrest, b","filed_date":"2023-08-04","accession":"0001410578-23-001557","full_text":"https://origin.rootz.global/static/filing/0001410578-23-001557.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":100,"match_count":12,"context":"ement of loss and comprehensive loss for the year ended December 31, 2021. *Asset Acquisitions* *Acquisition of MJ Distributing C201, LLC and MJ Distributing P132, LLC* On April 10, 2019, the Company entered into a definitive agreement to acquire100% of the membership interests in MJ Distributing C201, LLC and MJ Distributing P132, LLC (**MJ Distributing**) which currently hold licenses to cultivate and distribute, respectively, me","filed_date":"2023-08-04","accession":"0001410578-23-001557","full_text":"https://origin.rootz.global/static/filing/0001410578-23-001557.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":39,"context":"good standing in all jurisdictions where it does business or owns assets, except, in the case of this clause (ii), where the failure to be so qualified could not reasonably be expected to result in a Material Adverse Effect. (b)Each Borrower has the corporate or other organizational power and authority to execute, deliver and carry out the terms and provisions of this Amendment and the other Credit Documents to which it","filed_date":"2023-05-15","accession":"0001558370-23-009838","full_text":"https://origin.rootz.global/static/filing/0001558370-23-009838.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":14,"context":"ncial condition, results of operations, and cash flow may be negatively impacted by challenging global economic conditions. Epidemics and pandemics, including the recent COVID-19 pandemic, may have a significant negative impact on our business and financial results. A return on our securities is not guaranteed. Our voting control is concentrated; approximately 35.0% of our voting power is held by our Executive Chairman. Our","filed_date":"2023-03-31","accession":"0001558370-23-005294","full_text":"https://origin.rootz.global/static/filing/0001558370-23-005294.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":16,"context":"ition, results of operations, and cash flow may be negatively impacted by challenging global economic conditions. | | | | | Epidemics and pandemics, including the recent COVID-19 pandemic, may have a significant negative impact on our business and financial results. | | | | | A return on our securities is not guaranteed. | | | | | Our voting control is concentrated given 36.7% of our voting power is held by our Chief Execut","filed_date":"2022-03-15","accession":"0001558370-22-003583","full_text":"https://origin.rootz.global/static/filing/0001558370-22-003583.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":38,"context":"good standing in all jurisdictions where it does business or owns assets, except, in the case of this clause (ii), where the failure to be so qualified could not reasonably be expected to result in a Material Adverse Effect. (b)Each Borrower has the corporate or other organizational power and authority to execute, deliver and carry out the terms and provisions of this Amendment and the other Credit Documents to which it","filed_date":"2022-02-03","accession":"0001558370-22-000766","full_text":"https://origin.rootz.global/static/filing/0001558370-22-000766.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":12,"context":"tion, results of operations, and cash flow may be negatively impacted by challenging global economic conditions. | | |  | | Epidemics and pandemics, including the recent COVID-19 pandemic, may have a significant negative impact on our business and financial results. | | |  | | A return on our securities is not guaranteed. | | |  | | Our voting control is concentrated given 37.2% of our voting power is held by our Chief Exec","filed_date":"2021-03-31","accession":"0001104659-21-044840","full_text":"https://origin.rootz.global/static/filing/0001104659-21-044840.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":100,"match_count":44,"context":"43 | | |  |  Section 4.4 |  No Conflict; Required Filings and Consents |  43 | | |  |  Section 4.5 |  Parent Securities Filings; Financial Statements |  45 | | |  |  Section 4.6 |  Absence of Parent Material Adverse Effect |  46 | | |  |  Section 4.7 |  No Undisclosed Liabilities |  46 | | |  |  Section 4.8 |  Litigation |  47 | | |  |  Section 4.9 |  Compliance With Laws |  47 | | |  |  Section 4.10 |  Information Sup","filed_date":"2026-07-30","accession":"0001104659-26-088659","full_text":"https://origin.rootz.global/static/filing/0001104659-26-088659.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":100,"match_count":3,"context":"s in Maryland. As consideration, the Company issued 37,035 shares valued at $0.4 million, issued a $0.4 million promissory note, and paid $0.4 million in cash to the sellers. In addition, the Company invested $4.9 million in HA-MD to repay all outstanding debt obligations and fund certain capital expenditures. The Company concluded it does not have control but does have the ability to exercise significant influence ov","filed_date":"2026-08-14","accession":"0001104659-26-097118","full_text":"https://origin.rootz.global/static/filing/0001104659-26-097118.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":96,"match_count":12,"context":"ing this information within 120 days after the end of the fiscal year covered by the Form 10-K. We have also revised the Exhibit Index in Part IV to include additional exhibits relating to one of our named executive officers. This Amendment No. 1 amends and restates in their entirety Items 10, 11, 12, 13 and 14 of Part III of the Original Form 10-K.  In addition, as required by Section 302 of the Sarbanes-Oxley Act of 2","filed_date":"2024-04-29","accession":"0001558370-24-006114","full_text":"https://origin.rootz.global/static/filing/0001558370-24-006114.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":72,"match_count":9,"context":"owth Annual Report. At December&#xa0;31, 2023 the NEOs had the following Goodness RSUs outstanding: Mr.&#xa0;Kingsley held 313,294 vested Goodness RSUs and 175,139 unvested RSUs that vest in two installments on the anniversaries of the grant date, March&#xa0;15, 2022, and 452,709 unvested RSUs that vest in two installments on the anniversaries of the grant date, December&#xa0;14, 2022; Mr.&#xa0;Helle","filed_date":"2024-05-10","accession":"0001140361-24-025320","full_text":"https://origin.rootz.global/static/filing/0001140361-24-025320.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":72,"match_count":9,"context":"oodness Growth Annual Report. At December 31, 2023 the NEOs had the following Goodness RSUs outstanding: Mr. Kingsley held 313,294 vested Goodness RSUs and 175,139 unvested RSUs that vest in two installments on the anniversaries of the grant date, March 15, 2022, and 452,709 unvested RSUs that vest in two installments on the anniversaries of the grant date, December 14, 2022; Mr. Heller held 39,804 v","filed_date":"2024-04-29","accession":"0001558370-24-006114","full_text":"https://origin.rootz.global/static/filing/0001558370-24-006114.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":72,"match_count":9,"context":"cultivation and production facility of approximately 90,000 square feet. Recent changes to the states qualifying conditions for medical cannabis patients have contributed to increases in patient enrollment, and the legislature also recently granted Vireo four additional dispensary licenses, all of which opened in the fourth quarter of 2020. These additional dispensary licenses, combined with the pot","filed_date":"2021-03-31","accession":"0001104659-21-044840","full_text":"https://origin.rootz.global/static/filing/0001104659-21-044840.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":72,"match_count":9,"context":"b Board have unanimously declared advisable and in the best interests of their respective companies and stockholders, this Agreement and the transactions contemplated by this Agreement, including the merger of Merger Sub with and into the Company, with the Company surviving as a direct wholly owned Subsidiary of Parent (the **Merger**), upon the terms and subject to the conditions and limitations set forth","filed_date":"2026-07-30","accession":"0001104659-26-088659","full_text":"https://origin.rootz.global/static/filing/0001104659-26-088659.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":64,"match_count":8,"context":"and one cultivation and production facility of approximately 90,000 square feet. Changes to the states qualifying conditions for medical cannabis patients have contributed to increases in patient enrollment.  Minnesota state licenses are renewed every year. Provided that the requisite renewal fees are paid, the renewal application is submitted in a timely manner, and no material violations are noted,","filed_date":"2026-03-17","accession":"0001104659-26-029561","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029561.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":63,"match_count":6,"context":"atement of loss and comprehensive loss for theyear ended December31, 2020. *Asset Acquisitions* *Acquisition of MJ Distributing C201, LLC and MJ Distributing P132, LLC* On April 10, 2019, the Company entered into a definitive agreement to acquire100% of the membership interests in MJ Distributing C201, LLC and MJ Distributing P132, LLC (**MJ Distributing**) which currently hold licenses to cultivate and distribute, respectively, me","filed_date":"2022-03-15","accession":"0001558370-22-003583","full_text":"https://origin.rootz.global/static/filing/0001558370-22-003583.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":58,"match_count":6,"context":"eeking to develop intellectual property that is complementary to our mission, including novel product formulations, novel delivery systems and harm-mitigation processes. For example, in July 2020, we entered into a licensing agreement with eBottles420 related to our patent-pending, terpene-preserving packaging system. We have developed proprietary cannabis strains, cultivation methods, carbon dioxide extraction, ethanol extraction","filed_date":"2021-03-31","accession":"0001104659-21-044840","full_text":"https://origin.rootz.global/static/filing/0001104659-21-044840.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"risk_factor","strength":57,"match_count":4,"context":"that sales could occur, could adversely affect the price of our Subordinate Voting Shares.** The sale by the Selling Securityholders of a significant number of Subordinate Voting Shares could have a material adverse effect on the market price of our Subordinate Voting Shares. In addition, the perception in the public markets that the Selling Securityholders may sell all or a portion of their Subordinate Voting Shares a","filed_date":"2025-12-09","accession":"0001104659-25-119699","full_text":"https://origin.rootz.global/static/filing/0001104659-25-119699.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":56,"match_count":7,"context":"cultivation and production facility of approximately 90,000 square feet. Recent changes to the states qualifying conditions for medical cannabis patients have contributed to increases in patient enrollment, and the legislature also recently granted Vireo Minnesota four additional dispensary licenses, all of which opened in the fourth quarter of 2020. These additional dispensary licenses, combined wi","filed_date":"2022-03-15","accession":"0001558370-22-003583","full_text":"https://origin.rootz.global/static/filing/0001558370-22-003583.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":52,"match_count":4,"context":"The Scotts Miracle-Gro Company, strengthening the Vireo balance sheet and creating a procurement platform to optimize supply chain management and drive cost efficiency across our portfolio. | | | | | Announced a definitive agreement with Glass House Brands Inc. (Glass House) to form a joint venture to combine each partys California dispensary operations in exchange for a 50% ownership interest, supported by a preferential supply","filed_date":"2026-08-11","accession":"0001104659-26-093723","full_text":"https://origin.rootz.global/static/filing/0001104659-26-093723.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":50,"match_count":5,"context":"ement of loss and comprehensive loss for the year ended December 31, 2021. *Asset Acquisitions* *Acquisition of MJ Distributing C201, LLC and MJ Distributing P132, LLC* On April 10, 2019, the Company entered into a definitive agreement to acquire100% of the membership interests in MJ Distributing C201, LLC and MJ Distributing P132, LLC (**MJ Distributing**) which currently hold licenses to cultivate and distribute, respectively, me","filed_date":"2023-03-31","accession":"0001558370-23-005294","full_text":"https://origin.rootz.global/static/filing/0001558370-23-005294.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":48,"match_count":6,"context":"cultivation and production facility of approximately 90,000 square feet. Recent changes to the states qualifying conditions for medical cannabis patients have contributed to increases in patient enrollment.  Minnesota state licenses are renewed every twoyears. Every twoyears, licensees are required to submit a renewal application with the commissioner at least sixmonths before its registration term","filed_date":"2024-04-01","accession":"0001558370-24-004519","full_text":"https://origin.rootz.global/static/filing/0001558370-24-004519.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":48,"match_count":6,"context":"t (as applicable), the Pre-CIC Benefits Continuation Payments or the Post-CIC Benefits Continuation Payments (as applicable), the Outplacement Payments, the Termination Date means the date on which a separation from service has occurred for purposes of Section 409A of the Internal Revenue Code, as amended, and the regulations and guidance thereunder (the Code). 5.3Resignation From Positions. Unless otherwise req","filed_date":"2023-12-12","accession":"0001104659-23-125336","full_text":"https://origin.rootz.global/static/filing/0001104659-23-125336.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":48,"match_count":6,"context":"cultivation and production facility of approximately 90,000 square feet. Recent changes to the states qualifying conditions for medical cannabis patients have contributed to increases in patient enrollment. The  58 [Table of Contents](#TOC) March2022 addition of dried raw cannabis to the list of allowed delivery methods, give our management team optimism that the Minnesota market remains a growth op","filed_date":"2023-08-04","accession":"0001410578-23-001557","full_text":"https://origin.rootz.global/static/filing/0001410578-23-001557.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":48,"match_count":6,"context":"Research Pilot Program, (b) Ohio Medical Solutions, Inc., an Ohio limited liability company, so long as 100.00% of the Capital Stock of such Person is sold on or before June 30, 2021, (c) 844 East Tallmadge LLC, an Ohio limited liability company, so long as 100.00% of the Capital Stock of such Person is sold on or before June 30, 2021, (d) each Person that (i) would be a Subsidiary of a Consolidated","filed_date":"2023-05-15","accession":"0001558370-23-009838","full_text":"https://origin.rootz.global/static/filing/0001558370-23-009838.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":40,"match_count":5,"context":"eement or the Plan, if Participant ceases to be a Service Provider, then all Restricted Stock Units subject to this Award that have not yet vested shall be forfeited. In the event of the Participants separation from service (as such term is defined in Section 409A of the Code and its related regulations (409A)) by the Company for Cause, all Restricted Stock Units, whether vested or unvested, shall be cancelled a","filed_date":"2024-06-06","accession":"0001104659-24-069083","full_text":"https://origin.rootz.global/static/filing/0001104659-24-069083.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":40,"match_count":5,"context":"cultivation and production facility of approximately 90,000 square feet. Recent changes to the states qualifying conditions for medical cannabis patients have contributed to increases in patient enrollment. The March 2022 addition of dried raw cannabis to the list of allowed delivery methods, give our management team optimism that the Minnesota market remains a growth opportunity for the Company. Mi","filed_date":"2023-03-31","accession":"0001558370-23-005294","full_text":"https://origin.rootz.global/static/filing/0001558370-23-005294.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":40,"match_count":5,"context":"earch Pilot Program, (b) Ohio Medical Solutions, Inc., an Ohio  13 limited liability company, so long as 100.00% of the Capital Stock of such Person is sold on or before June 30, 2021, (c) 844 East Tallmadge LLC, an Ohio limited liability company, so long as 100.00% of the Capital Stock of such Person is sold on or before June 30, 2021, (d) each Person that (i) would be a Subsidiary of a Consolidated","filed_date":"2022-02-03","accession":"0001558370-22-000766","full_text":"https://origin.rootz.global/static/filing/0001558370-22-000766.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":37,"match_count":4,"context":"a contra-liability, to be netted against the outstanding loan balance and amortized over the remaining life of the loan. On May 25, 2023, the Company and Grown Rogue International, Inc. (Grown Rogue) entered into a strategic agreement whereby Grown Rogue will support Goodness Growth in the optimization of its cannabis flower products, with a particular focus on improving the quality and yield of top-grade A cannabis flower across","filed_date":"2024-04-01","accession":"0001558370-24-004519","full_text":"https://origin.rootz.global/static/filing/0001558370-24-004519.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"platform_shift","strength":32,"match_count":4,"context":"25. Strategic Rationale The Mergers were undertaken to enhance the Companys scale, operational efficiencies, and geographic diversification, and to strengthen its competitive position in existing and new markets. Each Merger expanded the Companys cultivation, manufacturing, retail, and intellectual property capabilities and added experienced management teams and workforces. The Company believes the Mergers","filed_date":"2026-03-17","accession":"0001104659-26-029561","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029561.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"margin_pressure","strength":32,"match_count":4,"context":"sell proprietary and, where lawful, third-party cannabis products to retail customers and patients. | | Cultivation Facilities We have rights to operate cultivation facilities in six states. Although pricing pressure for dried flower in several mature cannabis markets has led some operators to eschew cultivation, in certain markets the transition from medical-only to adult-use cannabis has increased wholesale mar","filed_date":"2026-03-17","accession":"0001104659-26-029561","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029561.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":32,"match_count":4,"context":"f any outstanding debt of the Company not less than $80,000,000 at an effective interest rate of not more than 9.75% with the bonus amount equal to 1% of the amount refinanced, (ii)the acquisition or merger with any entity where the total enterprise value of such other entity is $100,000,000 or greater, (iii)a Change of Control transaction, and (iv)the consummation of a transaction raising additional capital","filed_date":"2025-03-10","accession":"0001104659-25-021954","full_text":"https://origin.rootz.global/static/filing/0001104659-25-021954.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":32,"match_count":4,"context":"Utah, with the combined total footprint spanning seven states, approximately 1,043,500 square feet of cultivation and manufacturing space across nine facilities, and 48 retail dispensaries. Vireo has signed definitive agreements to acquire Proper Brands in Missouri, Deep Roots Harvest in Nevada, and WholesomeCo Cannabis in Utah, while also signing a binding MOU to acquire The Flowery in Florida. In addition to expanding the","filed_date":"2024-12-23","accession":"0001104659-24-131371","full_text":"https://origin.rootz.global/static/filing/0001104659-24-131371.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":32,"match_count":4,"context":"equal to fifty percent (50%) of Employees annualized Base Salary as of the Termination Date, less all legally required and authorized deductions and withholdings, payable in substantially equal installments in accordance with the Companys regular payroll cycle during the twelve (12) month period immediately following the Termination Date, provided, however, that any installments that otherwise would","filed_date":"2023-12-12","accession":"0001104659-23-125336","full_text":"https://origin.rootz.global/static/filing/0001104659-23-125336.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":24,"match_count":3,"context":"anche vesting on December31, 2026. | | | (3) | RSUs that settle on the third anniversary of the grant date December14, 2022. | | | (4) | RSUs that 50% vest on December17, 2025, and vest in 12.5% installments every quarter thereafter until fully vested on December17, 2026. Once vested, these RSUs only settle upon separation from service | | | (5) | Options that fully vest on August22, 2025. | | | (6)","filed_date":"2025-05-09","accession":"0001140361-25-018064","full_text":"https://origin.rootz.global/static/filing/0001140361-25-018064.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":24,"match_count":3,"context":"from the Closing Date or the applicable Subsequent Funding Date, as applicable, at the Interest Rate and shall be due and payable in cash monthly on each Payment Date, in arrears, with the first installment being payable on the last day of the first month following the Closing Date. (b)[Reserved]. (c)Interest shall accrue on each Loan for the day on which the Loan is made, and shall not accrue on a L","filed_date":"2025-01-03","accession":"0001104659-25-000793","full_text":"https://origin.rootz.global/static/filing/0001104659-25-000793.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":24,"match_count":3,"context":"cb2e0e63d4fe59546a76eb2619b18 **Words:** 1,395 --- EX-99.1 5 tm2426103d1_ex99-1.htm EXHIBIT 99.1 **  Exhibit 99.1** **Vireo Growth Inc. Announces Leadership Transition** 10/10/2024 * Amber Shimpa promoted to the role of Chief Executive Officer * * Josh Rosen resigns from leadership and governance roles and retained as advisor * MINNEAPOLIS, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (\"Vireo\" or the \"Company\") (CS","filed_date":"2024-10-15","accession":"0001104659-24-108300","full_text":"https://origin.rootz.global/static/filing/0001104659-24-108300.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":24,"match_count":3,"context":"with the SVS compensation warrants and $0 in stock-based compensation was recorded in connection with the MVS warrants.  On May 25, 2023, the Company and Grown Rogue International, Inc. (Grown Rogue) entered into a strategic agreement whereby Grown Rogue will support Goodness Growth in the optimization of its cannabis flower products, with a particular focus on improving the quality and yield of top-grade A cannabis flower across","filed_date":"2023-11-14","accession":"0001558370-23-019027","full_text":"https://origin.rootz.global/static/filing/0001558370-23-019027.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":24,"match_count":3,"context":"with the SVS compensation warrants and $0 in stock-based compensation was recorded in connection with the MVS warrants.  On May 25, 2023, the Company and Grown Rogue International, Inc. (Grown Rogue) entered into a strategic agreement whereby Grown Rogue will support Goodness Growth in the optimization of its cannabis flower products, with a particular focus on improving the quality and yield of top-grade A cannabis flower across","filed_date":"2023-08-14","accession":"0001558370-23-014893","full_text":"https://origin.rootz.global/static/filing/0001558370-23-014893.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":24,"match_count":3,"context":"30b4684537a90ae2 **Words:** 626 --- EX-99.1 5 tm237268d1_ex99-1.htm EXHIBIT 99.1 **  Exhibit 99.1** ** ** *  **** **Goodness Growth Holdings Announces Management Reorganization** ** ** Josh Rosen promoted to role of Interim Chief Executive Officer * * * * Company Founder, Dr. Kyle Kingsley, to assume role of Executive Chairman * * * * Decentralized state market teams designed to improve operating and financial performance * *","filed_date":"2023-02-17","accession":"0001104659-23-023228","full_text":"https://origin.rootz.global/static/filing/0001104659-23-023228.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":24,"match_count":3,"context":"ment of loss and comprehensive loss for the three months ended March 31, 2021. Asset Acquisitions Acquisition of MJ Distributing C201, LLC and MJ Distributing P132, LLC On April 10, 2019, the Company entered into a definitive agreement to acquire 100% of the membership interests in MJ Distributing C201, LLC and MJ Distributing P132, LLC (**MJ Distributing**) which hold provisional licenses to cultivate and distribute, respectively,","filed_date":"2021-05-14","accession":"0001558370-21-007182","full_text":"https://origin.rootz.global/static/filing/0001558370-21-007182.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"strategic_event","strength":24,"match_count":3,"context":"gulation S-K, this section explains how the Companys compensation program is structured for its Chief Executive Officer and the other executive officers named in the Summary Compensation Table (the **named executive officers** or **NEOs**). 18 **Compensation Governance** The Board has not adopted any formal policies or procedures to determine the compensation of our directors or executive officers. The compensation of t","filed_date":"2021-04-28","accession":"0001104659-21-056008","full_text":"https://origin.rootz.global/static/filing/0001104659-21-056008.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"platform_shift","strength":24,"match_count":3,"context":"vities continue into 2027.\" **Q2 Highlights** | | | Completed its merger with Eaze Inc. (Eaze), with Eaze becoming a wholly owned subsidiary of the Company, deepening presence in Colorado, adding two new markets: California and Florida, and enhancing Vireos IP portfolio with a robust delivery platform. | | | | | Completed the acquisition of The Hawthorne Gardening Company LLC (Hawthorne) and its subsidiarie","filed_date":"2026-08-11","accession":"0001104659-26-093723","full_text":"https://origin.rootz.global/static/filing/0001104659-26-093723.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"VREOF","company":"Vireo Growth Inc.","exchange":"OTC","sector":"Pharmaceutical Preparations","signal_type":"ai_adoption","strength":24,"match_count":3,"context":"t (the **Co-Admin Agent**). The First Lien Term Loan provides for an aggregate principal amount of $120 million. The aggregate principal amount of the First Lien Term Loan amortizes in quarterly installments of $3 million. The Company will make such quarterly amortization payments commencing on December31, 2025 and on the last business day of each quarter thereafter through and including July 3, 2028","filed_date":"2026-08-14","accession":"0001104659-26-097118","full_text":"https://origin.rootz.global/static/filing/0001104659-26-097118.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"dafa3c40e791b4ecea0db408879fc85620035f366442fbaa7519918b8bcb0c38","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"984bf88312afd4de3cefb2d52a7007e6ba8bd1c60fcd8603b905cd154a5337e1","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":122,"hourly_limit":500,"remaining":378,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}